ShareValue scores for ALKALI.NSE: Valuation 43, Quality 29, Growth 40, Health 45.

Alkali Metals Limited logo

ALKALI.NSE
NSE

Alkali Metals Limited

₹68.70(+0.78%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

4% to 16%
Valuation
43
Fair Value
Price vs Value
Quality
29
Weak
Business Strength
Growth
40
Weak
Revenue & Earnings
Health
45
Moderate
Financial Stability
Momentum
86
Bullish
Price Trend

Company Details

About

Alkali Metals Limited manufactures and sells chemicals in India and internationally. The company offers API products, including benzocaine, fluconazole, loperamide hydrochloride, losartan potassium, metformin hydrochloride, phenylephrine hydrochloride, and rabeprazole sodium. It also provides pyridine, acetylpyridine, alkyl borate, aminopyridine, bipyridine, bromopyridine, chloropyridine, cyanopyridine, cyclic, diethylamino pyridine, ethoxypyridine, fluoropyridine, hydroxypyridine, methoxypyridine, nitropyridine, picolylalcohol, pyridine n-oxide, pyrimidine, quinoline, tetrazole, and triazole compounds; azaindole, potassium, sodium, and other metal derivatives; boronic acids, and DSSC and OLED materials; and organic, inorganic, and fine chemicals. The company's products are used in pharma intermediates, anti retrovirals, flu vaccines, antibiotics, cardio/anti inflammation, agrochemicals, and automobiles applications. Alkali Metals Limited was incorporated in 1968 and is based in Hyderabad, India.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026